(3S,5R,8R,9R,10R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

Details

Top
Internal ID c968ac96-e6b5-4384-8c81-f506f6b6048d
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Triterpenoids
IUPAC Name (3S,5R,8R,9R,10R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILES (Canonical) CC(C)C(=C)CCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C)O
SMILES (Isomeric) CC(C)C(=C)CC[C@@](C)([C@H]1CC[C@@]2([C@@H]1CC[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C)O
InChI InChI=1S/C31H54O2/c1-20(2)21(3)12-19-31(9,33)23-13-17-29(7)22(23)10-11-25-28(6)16-15-26(32)27(4,5)24(28)14-18-30(25,29)8/h20,22-26,32-33H,3,10-19H2,1-2,4-9H3/t22-,23+,24+,25-,26+,28+,29-,30-,31+/m1/s1
InChI Key GHYYPJMOIDQJRP-CFMDIQLFSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C31H54O2
Molecular Weight 458.80 g/mol
Exact Mass 458.412380961 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 9.10
Atomic LogP (AlogP) 7.78
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S,5R,8R,9R,10R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9969 99.69%
Caco-2 - 0.5472 54.72%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.7143 71.43%
Subcellular localzation Mitochondria 0.4758 47.58%
OATP2B1 inhibitior - 0.5758 57.58%
OATP1B1 inhibitior + 0.8949 89.49%
OATP1B3 inhibitior + 0.8695 86.95%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior + 0.6282 62.82%
P-glycoprotein inhibitior - 0.6219 62.19%
P-glycoprotein substrate - 0.8331 83.31%
CYP3A4 substrate + 0.6552 65.52%
CYP2C9 substrate - 0.5811 58.11%
CYP2D6 substrate - 0.7340 73.40%
CYP3A4 inhibition - 0.7968 79.68%
CYP2C9 inhibition - 0.9229 92.29%
CYP2C19 inhibition - 0.7885 78.85%
CYP2D6 inhibition - 0.9488 94.88%
CYP1A2 inhibition - 0.8874 88.74%
CYP2C8 inhibition - 0.6628 66.28%
CYP inhibitory promiscuity - 0.5600 56.00%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9200 92.00%
Carcinogenicity (trinary) Non-required 0.6374 63.74%
Eye corrosion - 0.9916 99.16%
Eye irritation - 0.9083 90.83%
Skin irritation + 0.5158 51.58%
Skin corrosion - 0.9531 95.31%
Ames mutagenesis - 0.8300 83.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6631 66.31%
Micronuclear - 0.9600 96.00%
Hepatotoxicity - 0.7448 74.48%
skin sensitisation + 0.5538 55.38%
Respiratory toxicity + 0.5778 57.78%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.9750 97.50%
Nephrotoxicity - 0.9288 92.88%
Acute Oral Toxicity (c) I 0.5667 56.67%
Estrogen receptor binding + 0.7286 72.86%
Androgen receptor binding + 0.7294 72.94%
Thyroid receptor binding + 0.6384 63.84%
Glucocorticoid receptor binding + 0.7837 78.37%
Aromatase binding + 0.7074 70.74%
PPAR gamma + 0.6367 63.67%
Honey bee toxicity - 0.6623 66.23%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity + 0.9930 99.30%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 99.34% 97.25%
CHEMBL218 P21554 Cannabinoid CB1 receptor 95.59% 96.61%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.52% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.03% 96.09%
CHEMBL2581 P07339 Cathepsin D 92.94% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.59% 97.09%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 91.33% 82.69%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.81% 94.45%
CHEMBL2996 Q05655 Protein kinase C delta 88.60% 97.79%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.44% 95.89%
CHEMBL221 P23219 Cyclooxygenase-1 87.09% 90.17%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.21% 100.00%
CHEMBL2179 P04062 Beta-glucocerebrosidase 84.10% 85.31%
CHEMBL4227 P25090 Lipoxin A4 receptor 84.03% 100.00%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 83.40% 89.05%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.35% 92.62%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 82.61% 96.77%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 82.15% 89.62%
CHEMBL3230 O95977 Sphingosine 1-phosphate receptor Edg-6 81.92% 94.01%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 81.54% 91.03%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 81.09% 92.88%
CHEMBL206 P03372 Estrogen receptor alpha 80.96% 97.64%
CHEMBL2815 P04629 Nerve growth factor receptor Trk-A 80.53% 87.16%
CHEMBL1937 Q92769 Histone deacetylase 2 80.33% 94.75%
CHEMBL5103 Q969S8 Histone deacetylase 10 80.26% 90.08%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 80.26% 97.14%
CHEMBL1966 Q02127 Dihydroorotate dehydrogenase 80.16% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 80.08% 95.93%

Cross-Links

Top
PubChem 101863233
NPASS NPC304962
LOTUS LTS0108029
wikiData Q105008817